Blog

Scaling Manufacturing Flexibility for Fill-Finish Commercial Success

Scaling Manufacturing Flexibility for Fill-Finish Commercial Success

Introduction Faced with shifting demand from global markets, pharma and biotech companies are recognizing a greater need for flexible capacity. Whether it's a move from clinical to commercial, opening new markets, or a switch to North American manufacturing as part of...

Four Reasons You Should Choose Lyophilization for Your Next Project

Four Reasons You Should Choose Lyophilization for Your Next Project

Introduction to Lyophilization Lyophilization, or "lyo" for short, is the process of freeze-drying or sublimating a drug product. This process involves freezing the material and then reducing the surrounding pressure to allow the frozen water to sublimate directly...

JHS is Now the Largest Manufacturer in Spokane

JHS is Now the Largest Manufacturer in Spokane

Leading the Way in Biomanufacturing Innovation Jubilant HollisterStier (JHS) is the largest manufacturer by number of employees in the Spokane area, according to the Spokane Journal of Business as of July 2025. As local manufacturers, we produce life-saving...

Celebrating Women’s History Month 2025 at JHS

Celebrating Women’s History Month 2025 at JHS

As we celebrate Women's History Month, we want to take a moment to honor the remarkable women who have shaped our industry and continue to drive our success at Jubilant HollisterStier (JHS). This year, we are especially proud to recognize the outstanding women at...

Quality Without Compromise: GMP Annex 1 for Sterile Manufacturing

Quality Without Compromise: GMP Annex 1 for Sterile Manufacturing

What is Annex 1? Effective August 2023, GMP Annex 1 establishes the regulatory standard for all sterile medical products sold in the EU and focuses on best practices for aseptic and terminal sterilization. The final section regarding lyophilization protocol became...

5 Trends Impacting CMOs in 2025

5 Trends Impacting CMOs in 2025

What are some of the biggest changes CMOs and their partners will see in 2025? We discuss developments in Annex 1 compliance, the BioSecure Act, AI drug development, supply chain challenges amid new tariffs, and pandemic preparedness strategies. 1. Annex 1 Continues...

The Benefits of Finding a Sterile Fill Finish CMO Partner

The Benefits of Finding a Sterile Fill Finish CMO Partner

Sterile fill finish contract manufacturing is a critical process that meets an increasing demand while providing specialized services to pharmaceutical companies. The global sterile fill finish pharmaceutical contract manufacturing market size was valued at $8.7...

2024 End-of-Year Recap: A Year of Excellence and Growth

2024 End-of-Year Recap: A Year of Excellence and Growth

2024 Accomplishments As we bid farewell to 2024, Jubilant HollisterStier is proud to celebrate a year defined by remarkable achievements, impactful collaborations, and a steadfast commitment to shaping the future of pharmaceutical manufacturing. Here’s a look back at...

Pharmaceutical Supply Chain Management Best Practices

Pharmaceutical Supply Chain Management Best Practices

The pharmaceutical industry's supply chain is a critical component of global healthcare, ensuring that medicines and vaccines reach patients safely and efficiently. The COVID-19 pandemic highlighted the vulnerabilities and challenges of these supply chains, disrupting...

Understanding GMP in Pharmaceutical Manufacturing

Understanding GMP in Pharmaceutical Manufacturing

Pharmaceutical contract manufacturers play a vital role in bringing potential life-saving products to market. With the intricate and complex aspects that come with manufacturing these products, it’s important that guidelines are set and met to maintain safety for...

Spokane Facility Expansion

Spokane Facility Expansion

Investing in People and Technology to Double Our Capacity Jubilant HollisterStier broke ground for our $285Mn Spokane facility expansion project on November 17, 2021. This expansion is made possible through external grants, including an investment to expand sterile...